Esperion Therapeutics Inc (ESPR)
P/OCF Ratio
-43.95×
TTM · Retrieved:
ESPR P/OCF Ratio
Current (TTM)-43.95×retrieved
Current (TTM)-43.95×retrieved
ESPR Quarterly P/OCF Ratio (-7.96× → -24.84×)
Latest values, visible window
High-resolution chart · PNG
ESPR p/ocf ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | P/OCF Ratio |
|---|---|
| -24.8434× | |
| 19.3561× | |
| -122.5168× | |
| -6.1667× | |
| -12.4812× | |
| -12.3097× | |
| -9.105× | |
| -61.3154× | |
| 8.773× | |
| -9.0697× | |
| -5.6731× | |
| -6.1353× | |
| -2.2945× | |
| -10.8354× | |
| -10.5524× | |
| -7.9579× | |
| -7.2539× | |
| -3.1925× | |
| -4.6088× | |
| -11.5878× | |
| -8.1855× | |
| -10.1963× | |
| -11.9354× | |
| 10.1838× | |
| -12.5122× | |
| -32.6467× | |
| -17.1658× | |
| -22.7599× | |
| 11.7657× | |
| -42.9961× | |
| -32.3631× | |
| -26.7372× | |
| -44.5236× | |
| -49.5063× | |
| -33.9569× | |
| -39.863× | |
| -23.2167× | |
| -17.307× | |
| -21.8347× | |
| -30.4789× | |
| -38.8674× | |
| -59.3191× | |
| -44.855× | |
| -213.2288× | |
| -205.8262× | |
| -94.9741× | |
| -43.7357× | |
| -40.1317× | |
| -25.5251× | |
| -27.9809× | |
| -60.2242× | |
| -64.2406× | |
| -80.4852× | |
| -58.78× | |
| -47.9316× | |
| -48.9261× | |
| -51.87× | |
| -9.3807× | |
| -10.0409× | |
| -8.7486× | |
| -10.8189× | |
| -9.0872× | |
| -8.6618× | |
| -8.3496× | |
| -9.6923× | |
| -11.1482× | |
| -9.2129× | |
| -9.5309× | |
| -5.303× | |
| -9.1606× | |
| -1.0189× | |
| -7.9629× |